← Leaderboards
Zihua Gong
Cleveland Clinic Lerner Com-Cwru
$3,014,487
Attributed
$3,014,487
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $405.1K · FY2015–25$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,014,487 · 2
By mechanism
R01$2,633,318 · 1
R21$381,169 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Nadeem Riaz$356,801
Others in their field
Top investigators on “P53-Binding Protein 1”
- Titia De Lange · Rockefeller University$9,703,427
- Junjie Chen · University Of Tx Md Anderson Can Ctr$7,853,917
- Dipanjan Chowdhury · Dana-Farber Cancer Inst$5,939,756
- Georges Mer · Mayo Clinic$4,809,825
- Dale A Ramsden · University Of North Carolina Chapel Hill$4,277,696
- Michel C Nussenzweig · California Institute Of Technology$4,089,999
Research focus
P53-Binding Protein 1Brca1 GeneProteinsRepairedDna DamageMalignant NeoplasmsPreventHomologous RecombinationMediatingRegulationRecombinational RepairDna Repair PathwayPathway InteractionsNonhomologous Dna End JoiningArtemisCellsDna RepairDouble Strand Break RepairBinding ProteinsAdp RibosylationMutatePost-Translational Protein ProcessingCancer TherapyAdaptor Signaling Protein
Grant awards (9)
The role of NUDT16 in DNA damage response and tumorigenesis$405,116
R01 · FY2025 · CA · contact PI
The role of NUDT16 in DNA damage response and tumorigenesis$405,116
R01 · FY2024 · CA · contact PI
DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells$360,922
R01 · FY2023 · CA · contact PI
DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells$360,922
R01 · FY2022 · CA · contact PI
DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells$368,288
R01 · FY2021 · CA · contact PI
DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells$366,954
R01 · FY2020 · CA · contact PI
DNA Repair Pathways Choice to Regulate Therapeutic Resistance in Cancer Cells$366,000
R01 · FY2019 · CA · contact PI
Targeting the DNA repair pathway choice in breast cancer treatment$172,369
R21 · FY2016 · CA · contact PI
Targeting the DNA repair pathway choice in breast cancer treatment$208,800
R21 · FY2015 · CA · contact PI